Celcuity Inc Science Day (Virtual) Transcript
Well, good morning, everyone. Thank you for joining us today. I'm Brian Sullivan, CEO and Co-Founder of Celcuity. We're excited to have the opportunity today to discuss our plan to develop gedatolisib to unlock the potential of treating cancers involving PI3K/mTOR signaling.
Joining me today from Celcuity are Lance Laing, CSO and my fellow Co-Founder, and Igor Gorbatchevsky, our Chief Medical Officer. I'm also especially pleased to introduce you to Dr. Sara Hurvitz and Dr. Karim Fizazi. Dr. Hurvitz is Professor of Medicine, Head of the Division of Hematology and Oncology and Senior Vice President of University of Washington, Fred Hutchinson Cancer Center. Her practice specialty is breast cancer and she served in leadership capacities for many of the major breast cancer studies conducted over the past decade.
Dr. Fizazi is Professor of Medicine and Head of the Genitourinary Group at Institute Gustav Roussy at the University of Paris-Saclay. He also serves as President of the Urogenital Study Group, France's National
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |